Control Allergic Itch & Earn Up To $90 in Rewards
Apoquel has been prescribed for over 13 million dogs1 and is #1 in pet owner and vet satisfaction.2,3*
Apoquel Rewards
Earn $1 for every 10 points to spend at the vet, or redeem your points for exclusive petcare merch.
Dog
Allergic Itch Relief
Daily
Tablet & Chewable
 Tablet Count |  Bronze Points |  Silver Points |  Gold Points |
|---|---|---|---|
| 30 | 70 | 90 | 110 |
| 45 | 110 | 140 | 170 |
| 60 | 140 | 180 | 210 |
| 100 | 270 | 350 | 410 |
| 250 | 600 | 800 | 900 |
Join the Pack
Sign up for Rewards online or in our petcare app and start earning today.
IMPORTANT SAFETY INFORMATION: See full Apoquel Tablet and Apoquel Chewable Prescribing Information. Do not use Apoquel or Apoquel Chewable in dogs less than 12 months of age or those with serious infections. Apoquel and Apoquel Chewable may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre- existing cancers to get worse. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. New neoplastic conditions (benign and malignant) were observed in clinical studies and post- approval. Apoquel and Apoquel Chewable have not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. Apoquel and Apoquel Chewable have been used safely with many common medications including parasiticides, antibiotics and vaccines.
APOQUEL AND APOQUEL CHEWABLE INDICATIONS: Control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
*Vets, n=250; pet owners, n=491.
References:
- ZMR: GAH-284 Unique Patients Since Launch with Growth Rate June 2022
- Data on file, APOQUEL/CYTOPOINT Pet Tracker Wave 9, 2021, Zoetis Inc.
- Data on file, APOQUEL/CYTOPOINT Vet Tracker Wave 13, 2020, Zoetis Inc.
ZPR-00175R3
